Concepedia
Author
Linxin Xu
Also Known As
Lin-Xin Xu, Linxin Xu
31
Publications
1.1K
Citations
12
H-Index
0
Concepts
All Affiliations
×
All Concepts
1K
11
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Chenguang Li, Jie Zhang, Mei Xue, +10
Cardiovascular Diabetology
2019
560
Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway
Xiangyang Liu, Chaofei Xu, Linxin Xu, +7
Metabolism
2020
111
Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice
Mei Xue, Ting Li, Yue Wang, +9
Clinical Science
99
Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients
Jing Yang, Jinhua Yin, Gao Hong-fei, +4
Evidence-based Complementary and Alternative Medicine
2012
73
Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study
Ge Li, Linxin Xu, Yanglu Zhao, +9
PLoS ONE
2017
49
Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
Xiaochen Yu, Ziyu Meng, Ting Fang, +9
Frontiers in Physiology
2022
36
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
Ting Li, Ting Fang, Linxin Xu, +6
Frontiers in Pharmacology
2021
29
Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes
Linxin Xu, Chaofei Xu, Xiangyang Liu, +13
28
Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus
Linxin Xu, Ting Li, Jianhong Yin, +6
PeerJ
15
Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial
Xiangyang Liu, Jingrui Yao, Rong Xu, +7
Annals of Translational Medicine
Page 1